During the past decade, PMG Research of Piedmont HealthCare conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 11 clinical trials were completed, i.e. on average, 78.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PMG Research of Piedmont HealthCare" #1 sponsor was "Pfizer" with 7 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PMG Research of Piedmont HealthCare" #1 collaborator was "ASCLEPES Research Center" with 2 trials as a collaborator, "Eastside Research Associates" with 2 trials as a collaborator, "MRI Global" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "DuPage Medical Group" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "PMG Research of Piedmont HealthCare" are "Cardiovascular Disease" (2 trials), "Venous Thrombosis" (2 trials), "ASCVD" (1 trials), "Arthritis, Rheumatoid" (1 trials) and "Asymptomatic COVID-19" (1 trials). Many other conditions were trialed in "PMG Research of Piedmont HealthCare" in a lesser frequency.

Most popular intervention types in "PMG Research of Piedmont HealthCare" are "Drug" (13 trials), "Biological" (3 trials), "Diagnostic Test" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "bococizumab (PF-04950615)" (2 trials), "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "PMG Research of Piedmont HealthCare" are 20 trials for "All" genders.

Currently, there are NaN active trials in "PMG Research of Piedmont HealthCare". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in PMG Research of Piedmont HealthCare, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in PMG Research of Piedmont HealthCare, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".